We understand that businesses within life science face a rapidly evolving landscape with frequently changing regulatory requirements and a range of emerging risks.

— INDUSTRY

Life Sciences

Managing risk to protect your innovations

Contact us

Flexible approach, local knowledge, and a global reach

We understand that businesses within life science face a rapidly evolving landscape with frequently changing regulatory requirements and a range of emerging risks.

We have an intense focus on client service and a real passion to challenge and explore every aspect of risk associated with your business. This gives you the assurance of having a program that is tailored to your unique requirements.

In a changing insurance market, as specialists, we challenge our clients with fresh thinking and work with them to develop quality risk profiles to present to underwriters for optimum outcomes.

Being the world’s largest privately-owned insurance broker, our clients benefit from the strong relationships Lockton has built with domestic and international providers.

Our own Global Healthcare Network, gives us powerful leverage within the marketplace to successfully deliver cost-effective, bespoke insurance programs for each client’s individual requirements; without jeopardising coverage.

A creative and expanding range of solutions

We understand that the life sciences industry is different and a customised program is crucial in protecting businesses involved in pharmaceutical, research and development, medical device manufacturing, and human clinical trials. When it comes to managing risk it’s the quality of our thinking and our proactive approach that makes us different.

We also recognise the executive risk challenges faced by boards across the spectrum of life sciences and pharmaceutical companies, particularly those listed on the ASX. Whether it be renewal of your D&O liability insurance, coverage for a forthcoming initial public offering or new capital raising, we will work closely with you to ensure your program reflects your own risk appetite at a competitive premium.

Lockton is a member of AusBiotech, the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy.

Products and Services

By understanding what you do and what your individual needs are, we ensure there are no coverage gaps or overlaps within your insurance program including:

  • Life Science Insurance 

  • Clinical Trials Insurance, along with the ability to deliver quick issuance of certification

  • Product Liability

  • Property and Business Interruption, including supply chain risk

  • Professional Indemnity 

  • Directors & Officers

  • Cyber

  • Other specialised life sciences services, such as:

    • product recall;

    • medical malpractice;

    • supply chain risk review;

    • marine cargo;

    • employee benefits; and

    • additional industry solutions.

An industry-leading team of experts focused on the unique risks facing the life sciences industry.

Key Contacts

Placeholder image

Robert Giardina

Manager - Global Professional & Financial Risks
robert.giardina@lockton.com
+61 455 129 332

General Inquiries

Get in touch

info.au@lockton.com

We're here to help

We bring creative thinking and an entrepreneurial spirit to the insurance business and are uniquely positioned to help you succeed.

Talk to our team

Latest news and insights

Lockton, the world’s largest independent insurance broker, has appointed Mark Jones as its new International Chief Financial Officer (CFO), effective immediately. Lockton appoints Mark Jones as International Chief Financial Officer

Lockton appoints Mark Jones as International Chief Financial Officer

article
London, February 4th 2025 – Lockton, the world’s largest independent insurance broker, has appointed Mark Jones as its new International Chief Financial Officer (CFO), effective immediately. Mark has over two decades of financial leadership experience in the ...
Read moreLockton appoints Mark Jones as International Chief Financial Officer

Preparing for the New Aged Care Act: Key changes for registered providers

Explore the key changes introduced by the new Aged Care Act, effective 1 July 2025. This article summarises the significant updates and their impact on aged care service providers, including new regulatory models, strengthened quality standards, and enhanced worker screening. Stay informed about the latest developments in aged care governance and compliance.Explore the key changes introduced by the new Aged Care Act, effective 1 July 2025. This article summarises the significant updates and their impact on aged care service providers, including new regulatory models, strengthened quality standards, and enhanced worker screening. Stay informed about the latest developments in aged care governance and compliance.

AI Adoption for Professional Services: Rewards vs. Risks

• Whilst artificial intelligence (AI) is undeniably a useful tool, the velocity in which AI has continued to develop and the varying platform options available, could leave firms exposed. • Misinformation and disinformation pose serious business and ethical risks to companies, especially those utilising AI technology for consulting and advisory services. • The input of mass data, including confidential and sensitive personal information will need to be carefully considered as AI can be manipulated by threat actors. Firms can also be vulnerable to the security controls AI platforms have in place. Heavy fines and regulatory action are possible, and, in some scenarios, prosecution could occur. • Following the Privacy Act reforms, firms will need to revisit their existing policies and procedures to ensure privacy data obligations are being considered and met when using AI. • Whilst artificial intelligence (AI) is undeniably a useful tool, the velocity in which AI has continued to develop and the varying platform options available, could leave firms exposed. • Misinformation and disinformation pose serious business and ethical risks to companies, especially those utilising AI technology for consulting and advisory services. • The input of mass data, including confidential and sensitive personal information will need to be carefully considered as AI can be manipulated by threat actors. Firms can also be vulnerable to the security controls AI platforms have in place. Heavy fines and regulatory action are possible, and, in some scenarios, prosecution could occur. • Following the Privacy Act reforms, firms will need to revisit their existing policies and procedures to ensure privacy data obligations are being considered and met when using AI.

Preparing for the New Aged Care Act: Risk and insurance implications for aged care service providers

The new Aged Care Act, effective July 1, 2025, introduces significant changes for aged care service providers. These changes bring new governance, risk, and insurance implications. This article explores key risk and insurance impacts for aged care providers and offers actionable strategies to mitigate these risks.The new Aged Care Act, effective July 1, 2025, introduces significant changes for aged care service providers. These changes bring new governance, risk, and insurance implications. This article explores key risk and insurance impacts for aged care providers and offers actionable strategies to mitigate these risks.
See all news and insights

With a global footprint of 135+ offices, there’s sure to be one near you.

Find an office
*135+ Lockton offices and partner offices worldwide
Lockton blue globe